To study the correlation of high sensitivity C reactive protein levels with asthma control in children

Nithiyanantham Ramakrishnan, Shobhana Sivathanu, Sowmya Sampath, Suresh David JH, Thuthi Mohan


Background: Childhood asthma appears to be increasing in prevalence despite advancements in the care of asthma. In asthma, local as well as systemic inflammation contributes to the pathogenesis. Thus successful management depends on controlling this inflammation by appropriate doses of inhaled corticosteroids. High sensitivity C reactive protein (hsCRP) is an easily measurable marker of inflammation and its level can be used as a diagnostic tool in assessing control of asthma. The objective of this study was study the correlation of serum hsCRP levels with asthma control in children

Methods: It is an observational study conducted in the Pediatric asthma clinic of a Government Medical College in south India. The study population consisted of 75 asthmatic children aged 5-15 years. Children with persistent asthma were classified into three groups based on GINA guidelines. Serum hsCRP levels were measured in all the three groups.

Results: Among the 75 children 33% belonged to controlled group, 35% to uncontrolled group and 33% to partly controlled group. There was a significant difference in hsCRP levels between controlled and uncontrolled groups. The mean value of hsCRP in controlled group was 0.93±1.3 mg/L whereas in the uncontrolled group it was 2.73±2.46 mg/L. Higher levels of hsCRP were found in the uncontrolled asthma group.

Conclusions: There is an inverse correlation between hsCRP levels and asthma control in children. High hsCRP levels have a potential to be used as a surrogate marker for poor control of asthma and can thus be used as a guide for adjustment of dosage of inhaled corticosteroids. 


Asthma control, Children, Correlation, GINA guidelines, hsCRP

Full Text:



Sahoo RC, Acharya PR, Noushad TH, Anand R, Acharya VK, Sahu KR. A study of high-sensitivity C-reactive protein in bronchial asthma. Indian J Chest Dis Allied Sci. 2009;51:215.

Pepys MB, Batz ML. Acute phase protein with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid a protein. Adv Immunol. 1983;34:141-212.

Tilemanna L, Gindnerb L, Meyerc F, Szecsenyib J, Schneidera A. Research paper differences in local and systemic inflammatory markers in patients with obstructive airways disease. Prim Care Respir J. 2011;20:407-14.

Elbehidy RM, Amr GE, Radwan HM. High sensitivity-C reactive protein as a novel marker for airway inflammation and steroid responsiveness in asthmatic children. Egypt J Bronchol. 2010;4:79-87.

Olafsdottir IS Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jögi R, et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax. 2005;60(6):451-4.

Qian FH, Zhang Q, Zhou LF, Liu H, Huang M, Zhang XL, et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respirology. 2008;13(5):664-9.

Albana EAM, Salah KM, Ahmed HS. Effects of vitamin D and microbial peptide in asthma. Egypt J Pediatr Allergy Immunol. 2012;10(2):101-7.

Kilic H, Karalezli A, Hasanoglu C, Erel O, Ates C. The relationship between hsCRP and asthma control test in asthmatic patients. Allergol Immunopathol (Madr). 2012;40(6):362-7.

Razi E, Hassan E, Hossein A, Vajihe C, Armin R. Evaluation of high-sensitivity C-reactive protein in acute asthma. Tanaffos. 2012;11(1):32-7.